Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF.

Nat Med. 2003 Jun;9(6):727-8. Epub 2003 May 18.

PMID:
12754504
[PubMed - indexed for MEDLINE]
2.

Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy.

Frenkel LM, Wang Y, Learn GH, McKernan JL, Ellis GM, Mohan KM, Holte SE, De Vange SM, Pawluk DM, Melvin AJ, Lewis PF, Heath LM, Beck IA, Mahalanabis M, Naugler WE, Tobin NH, Mullins JI.

J Virol. 2003 May;77(10):5721-30.

PMID:
12719565
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.

Markowitz M, Louie M, Hurley A, Sun E, Di Mascio M, Perelson AS, Ho DD.

J Virol. 2003 Apr;77(8):5037-8.

PMID:
12663814
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy.

Dybul M, Daucher M, Jensen MA, Hallahan CW, Chun TW, Belson M, Hidalgo B, Nickle DC, Yoder C, Metcalf JA, Davey RT, Ehler L, Kress-Rock D, Nies-Kraske E, Liu S, Mullins JI, Fauci AS.

J Virol. 2003 Mar;77(5):3229-37.

PMID:
12584346
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Latency in human immunodeficiency virus type 1 infection: no easy answers.

Persaud D, Zhou Y, Siliciano JM, Siliciano RF.

J Virol. 2003 Feb;77(3):1659-65. Review. No abstract available.

PMID:
12525599
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.

Ruff CT, Ray SC, Kwon P, Zinn R, Pendleton A, Hutton N, Ashworth R, Gange S, Quinn TC, Siliciano RF, Persaud D.

J Virol. 2002 Sep;76(18):9481-92.

PMID:
12186930
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

T cell memory.

Sprent J, Surh CD.

Annu Rev Immunol. 2002;20:551-79. Epub 2001 Oct 4. Review.

PMID:
11861612
[PubMed - indexed for MEDLINE]
8.

The challenge of viral reservoirs in HIV-1 infection.

Blankson JN, Persaud D, Siliciano RF.

Annu Rev Med. 2002;53:557-93. Review.

PMID:
11818490
[PubMed - indexed for MEDLINE]
9.

Principles and practice of HIV-protease inhibitor pharmacoenhancement.

Moyle GJ, Back D.

HIV Med. 2001 Apr;2(2):105-13. Review.

PMID:
11737387
[PubMed - indexed for MEDLINE]
10.

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.

Hermankova M, Ray SC, Ruff C, Powell-Davis M, Ingersoll R, D'Aquila RT, Quinn TC, Siliciano JD, Siliciano RF, Persaud D.

JAMA. 2001 Jul 11;286(2):196-207.

PMID:
11448283
[PubMed - indexed for MEDLINE]
11.

Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology.

Rouzine IM, Rodrigo A, Coffin JM.

Microbiol Mol Biol Rev. 2001 Mar;65(1):151-85. Review.

PMID:
11238990
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, Hellmann NS, Petropoulos CJ, McCune JM, Hellerstein MK, Grant RM.

N Engl J Med. 2001 Feb 15;344(7):472-80.

PMID:
11172188
[PubMed - indexed for MEDLINE]
Free Article
13.

Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy.

Imamichi H, Crandall KA, Natarajan V, Jiang MK, Dewar RL, Berg S, Gaddam A, Bosche M, Metcalf JA, Davey RT Jr, Lane HC.

J Infect Dis. 2001 Jan 1;183(1):36-50. Epub 2000 Dec 8.

PMID:
11106537
[PubMed - indexed for MEDLINE]
Free Article
14.

Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy.

Zhang L, Chung C, Hu BS, He T, Guo Y, Kim AJ, Skulsky E, Jin X, Hurley A, Ramratnam B, Markowitz M, Ho DD.

J Clin Invest. 2000 Oct;106(7):839-45.

PMID:
11018071
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

Chun TW, Davey RT Jr, Ostrowski M, Shawn Justement J, Engel D, Mullins JI, Fauci AS.

Nat Med. 2000 Jul;6(7):757-61.

PMID:
10888923
[PubMed - indexed for MEDLINE]
16.

Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses.

Luzuriaga K, McManus M, Catalina M, Mayack S, Sharkey M, Stevenson M, Sullivan JL.

J Virol. 2000 Aug;74(15):6984-91.

PMID:
10888637
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.

Pierson T, McArthur J, Siliciano RF.

Annu Rev Immunol. 2000;18:665-708. Review.

PMID:
10837072
[PubMed - indexed for MEDLINE]
18.

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.

Persaud D, Pierson T, Ruff C, Finzi D, Chadwick KR, Margolick JB, Ruff A, Hutton N, Ray S, Siliciano RF.

J Clin Invest. 2000 Apr;105(7):995-1003.

PMID:
10749578
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.

Havlir DV, Hellmann NS, Petropoulos CJ, Whitcomb JM, Collier AC, Hirsch MS, Tebas P, Sommadossi JP, Richman DD.

JAMA. 2000 Jan 12;283(2):229-34.

PMID:
10634339
[PubMed - indexed for MEDLINE]
20.

Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.

Dornadula G, Zhang H, VanUitert B, Stern J, Livornese L Jr, Ingerman MJ, Witek J, Kedanis RJ, Natkin J, DeSimone J, Pomerantz RJ.

JAMA. 1999 Nov 3;282(17):1627-32.

PMID:
10553788
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk